NIH Funding Cuts Are Pushing Biomedical Labs to the Brink, Survey Finds
By FieldPulse Staff · March 19, 2026
Tags: strategy, leadership
STAT survey of 1,000 researchers: 26% laid off lab staff, 40% canceled research, 66% counseled students to leave academia. NIH distributed 74% fewer new competitive grants through early March.
A nationwide survey of nearly 1,000 NIH-funded researchers published by STAT News on March 19, 2026 found that more than a quarter had already laid off lab members, over 40% had canceled planned research projects, and two-thirds had counseled students to consider careers outside academia — all as a direct result of ongoing federal funding cuts and grant processing delays.
The NIH had distributed 74% fewer new competitive grant awards through early March compared to the same period averaged over fiscal years 2021–2024.
Training grants, which support the next generation of biomedical scientists, have been similarly stalled, creating compounding damage to the long-term U.S.
research pipeline.
The findings carry direct implications for pharma: academic labs are a primary source of early-stage discovery research that feeds the biopharma pipeline.
If the funding disruption persists through mid-2026, analysts expect a meaningful slowdown in early-stage licensing deals and academic partnership activity, particularly for specialty and rare disease areas that rely heavily on NIH-funded basic science.